ID
27978
Description
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Visit: All visits. Quelle: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Keywords
Versions (2)
- 12/7/17 12/7/17 -
- 1/1/18 1/1/18 -
Copyright Holder
Prof. Dr. med. Georg Heß
Uploaded on
December 7, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Chemotherapy Regimen GOAL Trial B-cell Lymphoma NCT02499003
Chemotherapy Regimen GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Description
Chemotherapy Regimen
Description
Order (O=Obinutuzumab, P=Pixantrone): O, O, P, O, P, O, P, O, P, P, P, O, P, P, P, O, P, P, P, O, P, P, P, O, P, P, P
Data type
text
Description
Order: 1, 1, 1, 1, 1, 1, 1, 2, 2, 2, 2, 3, 3, 3, 3, 4, 4, 4, 4, 5, 5, 5, 5, 6, 6, 6, 6
Data type
integer
Description
Order: ns, ns, 1, 8, 8, 15, 15, 1, 1, 8, 15, 1, 1, 8, 15, 1, 1, 8, 15, 1, 1, 8, 15, 1, 1, 8, 15
Data type
text
Description
Calculated date of administration
Data type
date
Description
Calculated date correct
Data type
boolean
Description
Date of administration
Data type
date
Description
Dose chemotherapy
Data type
integer
Measurement units
- mg
Description
chemotherapy dose skipped
Data type
boolean
Description
Chemotherapy comment
Data type
text
Similar models
Chemotherapy Regimen GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM